Michelle Sholzberg




Dr. Michelle Sholzberg received her MDCM and residency training in Internal Medicine at McGill University, completed additional postgraduate training in Hematology at the University of Toronto and a research hemostasis fellowship in Toronto and internationally. Dr. Sholzberg has a Master of Science from the University of Toronto in Clinical Epidemiology and Health Care Research and was awarded the Claire Bombardier award for career promise as a scientist. She is a clinician-investigator with a focus on coagulation, the Division Head of Hematology-Oncology and the Medical Director of the Coagulation Laboratory at St. Michael’s Hospital. She is also the Director of the Hematology-Oncology Clinical Research Group and Co-director of the Hematology-Immunology Translational Research Theme of the Li Ka Shing Knowledge Institute. Currently, she is involved in the study of: prediction tools for perioperative and traumatic bleeding, the intersection of women’s health and bleeding disorders, treatments for iron deficiency anemia, new treatments for immune thrombocytopenia and the management of COVID-19 coagulopathy.

Recent Publications

  1. Baumann Kreuziger, L, Sholzberg, M, Cushman, M. Anticoagulation in Hospitalized Patients with COVID-19. Blood. 2022; :. doi: 10.1182/blood.2021014527. PubMed PMID:35653590 .
  2. Nersesian, S, Sholzberg, M, Cushman, M, Wolberg, AS. The Journey to a Successful Illustrated Review. Res Pract Thromb Haemost. 2022;6 (4):e12721. doi: 10.1002/rth2.12721. PubMed PMID:35599704 PubMed Central PMC9115973.
  3. Weyand, AC, Sidonio, RF Jr, Sholzberg, M. Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues. Haemophilia. 2022;28 Suppl 4 :18-25. doi: 10.1111/hae.14535. PubMed PMID:35521724 .
  4. Kron, A, Del Giudice, ME, Sholzberg, M, Callum, J, Cserti-Gazdewich, C, Swarup, V et al.. Daily versus every other day oral iron supplementation in patients with iron deficiency anemia (DEODO): study protocol for a phase 3 multicentered, pragmatic, open-label, pilot randomized controlled trial. Pilot Feasibility Stud. 2022;8 (1):98. doi: 10.1186/s40814-022-01042-y. PubMed PMID:35509085 PubMed Central PMC9064727.
  5. Xu, Y, Gomes, T, Wells, PS, Pequeno, P, Johnson, A, Sholzberg, M et al.. Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study. Thromb Res. 2022;213 :57-64. doi: 10.1016/j.thromres.2022.02.018. PubMed PMID:35298939 .
  6. Lee, SG, Fralick, J, Wallis, CJD, Boctor, M, Sholzberg, M, Fralick, M et al.. Systematic review of hematuria and acute renal failure with tranexamic acid. Eur J Haematol. 2022;108 (6):510-517. doi: 10.1111/ejh.13762. PubMed PMID:35266205 .
  7. Sholzberg, M, da Costa, BR, Tang, GH, Rahhal, H, AlHamzah, M, Baumann Kreuziger, L et al.. Randomized trials of therapeutic heparin for COVID-19: A meta-analysis. Res Pract Thromb Haemost. 2021;5 (8):e12638. doi: 10.1002/rth2.12638. PubMed PMID:34977448 PubMed Central PMC8681879.
  8. Weyand, AC, McGann, PT, Sholzberg, M. Sex specific definitions of anaemia contribute to health inequity and sociomedical injustice. Lancet Haematol. 2022;9 (1):e6-e8. doi: 10.1016/S2352-3026(21)00351-3. PubMed PMID:34971584 .
  9. Kamin Mukaz, D, Gergi, M, Koh, I, Zakai, NA, Judd, SE, Sholzberg, M et al.. Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study. Res Pract Thromb Haemost. 2021;5 (8):e12632. doi: 10.1002/rth2.12632. PubMed PMID:34934895 PubMed Central PMC8652130.
  10. Kaur, MN, Arnold, DM, Heddle, NM, Cook, RJ, Hsia, C, Blostein, M et al.. Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. Blood Adv. 2022;6 (3):785-792. doi: 10.1182/bloodadvances.2021005627. PubMed PMID:34781363 PubMed Central PMC8945289.
Search PubMed

Affiliations & Other Activities

  • Staff Physician, Division of Hematology, St. Michael’s Hospital
  • Assistant Professor, Department of Medicine, University of Toronto